Healthcare & Life Sciences

medarex

United States
pre-ipo
pre-ipo
Stage

About

Medarex was a biopharmaceutical company specializing in the discovery, development, and commercialization of therapeutic antibodies for cancer and autoimmune disorders.

Explore medarex's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.